Clinton Branch
Neurology · Gainesville, GANPI 1184739435
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Acorda Therapeutics, Inc accounts for 68.8% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $6,634 and has fallen 98.3% since, to $114 in 2025.
Across 99 payments — averaging $79.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acorda Therapeutics, Inc$5K
- Teva Pharmaceuticals USA, Inc.$907
- AstraZeneca$162
- AbbVie$113
- EMD Serono, Inc.$108
- Eisai Inc.$102
- plus $1K from 26 others
What the payments were for
- Speaking & faculty fees$4,27155%
- Travel & lodging$1,32417%
- Food & beverage$2,24129%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acorda Therapeutics, Inc | 14 | $5,392 |
| Teva Pharmaceuticals USA, Inc. | 11 | $907 |
| AstraZeneca(2 entities) | 3 | $162 |
| AbbVie(2 entities) | 6 | $113 |
| EMD Serono, Inc. | 8 | $108 |
| Eisai Inc. | 4 | $102 |
| Acadia Pharmaceuticals Inc | 5 | $90 |
| UCB, Inc. | 5 | $85 |
| Sanofi | 3 | $75 |
| Ipsen Biopharmaceuticals, Inc | 4 | $72 |
| Avanir Pharmaceuticals, Inc. | 3 | $66 |
| Upsher-smith Laboratories LLC | 3 | $60 |
| Biogen | 3 | $59 |
| Kyowa Kirin, Inc. | 3 | $52 |
| Tanabe Pharma America, Inc. | 2 | $42 |
| Novartis | 2 | $42 |
| CSL Behring | 1 | $40 |
| Boston Scientific | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Amylyx Pharmaceuticals, Inc. | 1 | $33 |
| MDD US Operations, LLC | 2 | $32 |
| GE HealthCare | 2 | $31 |
| Neurelis, Inc. | 1 | $29 |
| Argenx US, Inc. | 1 | $28 |
| Sunovion Pharmaceuticals Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Amgen | 1 | $20 |
| Grifols USA, LLC | 1 | $18 |
| Merz North America, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,836 in reported general payments places this provider in the 75th percentile of 506 neurology providers in Georgia.
Other neurology in Gainesville
- Daniel CobbGainesville$81K
- Michael BaughGainesville$23K
- Mitzi WilliamsSmyrna$1.4M
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- John MorganAugusta$715K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Sudhir AthniMacon$432K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.